Restenosis after balloon angioplasty of coarctation: relationship with ductus arteriosus.
BACKGROUND
Recently, balloon angioplasty (BA) has been used for the treatment of coarctation of the aorta (CoA) and the effectiveness of this treatment has been reported. However, the restenosis rate following BA in native CoA in the infant is high and the cause may be related to tissue properties at the origin of the ductus arteriosus (DA). However, the mechanisms responsible for restenosis remain uncertain.


RESULTS
The present study was designed to examine transformation of the smooth muscle cell (SMC) phenotypes using immunohistologic studies and to investigate the cause of restenosis of CoA following BA. A CoA model was surgically created in 15 newborn pigs (10-14-days-old; 2.4-4.1 kg). Balloon angioplasty was performed 1 month after the initial operation. One or 3 months after BA, animals were killed and immunohistologic studies on smooth muscle cell (SMC) antibodies against SM1, SM2 and SMemb of the myosin heavy chain (MHC) isoform were performed in the aorta at the CoA and DA. In the neointima, only SMemb was positive. In the SMC layer of the DA, only SM2 was positive. One month after BA, the external layer of the tunica media was strongly positive for SM2 only in the area around the origin of the DA.


CONCLUSIONS
The first cause of restenosis is obstructive neointimal formation caused by the proliferation of undifferentiated SMC into the subendothelial tissue. This proliferation seems to be triggered by BA. The distribution of SM2 1 month after balloon angioplasty showed a similar pattern of proliferation of SMC in the external layer around the DA. This may represent a second mechanism of restenosis.
Takahashi
K
K
Department of Pediatrics, Juntendo University School of Medicine, Tokyo, Japan.
Ino
T
T
Ohkubo
M
M
Akimoto
K
K
Kishirou
M
M
D000800:Angioplasty, Balloon / Q000009:adverse effects; D000818:Animals; D000906:Antibodies / Q000032:analysis; D001011:Aorta / Q000473:pathology*; D001017:Aortic Coarctation / Q000150:complications / Q000473:pathology / Q000628:therapy*; D002454:Cell Differentiation; D002455:Cell Division; D004195:Disease Models, Animal; D004373:Ductus Arteriosus / Q000473:pathology; D007150:Immunohistochemistry; D008854:Microscopy, Electron; D009131:Muscle, Smooth, Vascular / Q000166:cytology* / Q000276:immunology / Q000473:pathology; D018995:Myosin Heavy Chains / Q000276:immunology; D012008:Recurrence; D013552:Swine; D016896:Treatment Outcome; D017539:Tunica Intima / Q000166:cytology* / Q000473:pathology / Q000648:ultrastructure
D000906:Antibodies; D018995:Myosin Heavy Chains